10 U.S.C. § 1107
Notice of use of an investigational new drug or a drug unapproved for its applied use
United States · Title 10 — ARMED FORCES · Status: effective
Cite this
- Citation
- 10 U.S.C. § 1107, Notice of use of an investigational new drug or a drug unapproved for its applied use, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/433231
- Permanent ID
ys:prov:433231@1- SHA-256
78e9ad2afdcda4bb8734ac929c19df6285fbb9112141e8d4212939adfea1d41b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
The notice required under subsection (a)(1) shall include the following:
The Secretary of Defense shall ensure that the medical records of members accurately document—
The Secretary of Defense may request the President to waive the prior consent requirement with respect to the administration of an investigational new drug or a drug unapproved for its applied use to a member of the armed forces in connection with the member’s participation in a particular military operation. With respect to any such administration—
In this subsection:
In this section:
Legislative history
The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.
- National Defense Authorization Act for Fiscal Year 1998
- Strom Thurmond National Defense Authorization Act for Fiscal Year 1999
- National Defense Authorization Act for Fiscal Year 2000
- National Defense Authorization Act for Fiscal Year 2004
- Ronald W. Reagan National Defense Authorization Act for Fiscal Year 2005House: 359–14Senate: no recorded tally